Skip to main content

Lisinopril Tablets

Last Updated: January 15, 2023
Status: Current

Products Affected - Description
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 90 count, NDC 76282-0419-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 180 count, NDC 76282-0420-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 76282-0420-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 5000 count, NDC 76282-0420-50
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 90 count, NDC 68180-0514-09 - discontinued
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 5000 count, NDC 68180-0980-30 - discontinued
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 90 count, NDC 68180-0512-09 - discontinued
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 90 count, NDC 68180-0515-09 - discontinued
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 90 count, NDC 68180-0516-09 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 90 count, NDC 68180-0517-09 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 100 count, NDC 68180-0517-01 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 1000 count, NDC 68180-0517-03 - discontinued
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 90 count, NDC 68180-0513-09 - discontinued
    • Lisinopril oral tablet, Major, 5 mg, unit-dose blister pack, 100 count, NDC 00904-6797-61
    • Lisinopril oral tablet, Teva, 10 mg, bottle, 100 count, NDC 00591-0407-01
    • Lisinopril oral tablet, Teva, 10 mg, bottle, 1000 count, NDC 00591-0407-10
    • Lisinopril oral tablet, Teva, 2.5 mg, bottle, 100 count, NDC 00591-0405-01
    • Lisinopril oral tablet, Teva, 2.5 mg, bottle, 500 count, NDC 00591-0405-05
    • Lisinopril oral tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0408-01
    • Lisinopril oral tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0408-10
    • Lisinopril oral tablet, Teva, 30 mg, bottle, 100 count, NDC 00591-0885-01
    • Lisinopril oral tablet, Teva, 40 mg, bottle, 100 count, NDC 00591-0409-01
    • Lisinopril oral tablet, Teva, 40 mg, bottle, 500 count, NDC 00591-0409-05
    • Lisinopril oral tablet, Teva, 5 mg, bottle, 100 count, NDC 00591-0406-01
    • Lisinopril oral tablet, Teva, 5 mg, bottle, 1000 count, NDC 00591-0406-10
Reason for the Shortage
    • Exelan did not provide a reason for the shortage.
    • Lupin has lisinopril tablets available.
    • Major did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
Available Products
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 45 count, NDC 76282-0419-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 100 count, NDC 76282-0419-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 76282-0419-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 76282-0417-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 500 count, NDC 76282-0417-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 45 count, NDC 76282-0420-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 90 count, NDC 76282-0420-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 100 count, NDC 76282-0420-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 100 count, NDC 76282-0421-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 500 count, NDC 76282-0421-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 45 count, NDC 76282-0422-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 90 count, NDC 76282-0422-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 100 count, NDC 76282-0422-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 180 count, NDC 76282-0422-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 1000 count, NDC 76282-0422-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 45 count, NDC 76282-0418-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 90 count, NDC 76282-0418-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 100 count, NDC 76282-0418-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 76282-0418-10
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 100 count, NDC 68180-0980-01
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 1000 count, NDC 68180-0980-03
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 100 count, NDC 68180-0512-01
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 500 count, NDC 68180-0512-02
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 100 count, NDC 68180-0981-01
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 1000 count, NDC 68180-0981-03
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 100 count, NDC 68180-0982-01
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 500 count, NDC 68180-0982-02
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 100 count, NDC 68180-0513-01
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 1000 count, NDC 68180-0513-03
    • Lisinopril oral tablet, Major, 10 mg, unit-dose blister pack, 100 count, NDC 00904-6798-61
    • Lisinopril oral tablet, Major, 20 mg, unit-dose blister pack, 100 count, NDC 00904-6799-61
    • Lisinopril oral tablet, Major, 40 mg, unit-dose blister pack, 100 count, NDC 00904-7200-61

Estimated Resupply Dates

    • Exelan has lisinopril 20 mg in 180 count, 1,000 count, and 5,000 count bottles on back order and the company cannot estimate a release date.
    • Major has lisinopril 5 mg tablets in unit-dose blister packs on back order and the company estimates a release date in late-January 2023.
    • Teva has all presentations on back order and the company cannot estimate a release date.

Updated

Updated January 15, 2023 by Elyse MacDonald, PharmD, MS, BCPS. Created June 30, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.